Bio-Rad Laboratories | BIO - Себестоимость





Себестоимость Изменить Дата
Abbott USD 5.94B 642M 2026-06
Agilent USD 836M 9M 2026-06
Becton, Dickinson and Co. USD 2.67B 108M 2026-06
Bio Techne USD 103.13M 1.47M 2026-03
Bio-Rad Laboratories USD 305.2M 22.5M 2026-06
Bruker USD 422.5M 21.1M 2026-06
Charles River Laboratories USD 655.29M 61.22M 2026-06
Danaher USD 2.65B 294M 2026-06
General Electric Aerospace USD 8.89B 736M 2026-06
Illumina USD 389M 19M 2026-06
IQVIA Holdings USD 3.22B 141M 2026-06
Laboratory Of America USD 2.7B 97.8M 2026-06
Merck USD 3.14B 200M 2026-06
Mettler Toledo International USD 396.52M 14.4M 2026-06
Myriad Genetics USD 63M 1.1M 2025-12
OraSure Technologies USD 15.43M 113K 2025-12
Pacific Biosciences Of California USD 28.9M 10M 2025-12
Quest Diagnostics USD 2.05B 64M 2026-06
Repligen USD 94.09M 8.12M 2026-06
Revvity USD 312.82M 10.64M 2026-06
Roche Holding CHF 7.85B 630M 2026-06
Siemens EUR 12.29B 218M 2026-06
Standard Biotools USD 9.84M 2.58M 2026-03
Thermo Fisher Scientific USD 7.54B 577M 2026-06
Tosoh JPY 199.55B 5.82B 2026-06
Waters USD 1.16B 430M 2026-06